Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic kidney disease
Pharma
FDA approves Corstasis' nasal spray as treatment for edema
The FDA has approved Corstasis Therapeutics’ nasal spray Enbumyst to relieve the edema associated with heart failure and kidney and liver disease.
Kevin Dunleavy
Sep 15, 2025 3:33pm
Ivonescimab, Fosun-Sitala, Hutchmed—Fierce Pharma Asia
Aug 29, 2025 8:15am
CSL's Venofer finally faces generic competition
Aug 13, 2025 2:06pm
FDA broadens label for Bayer's Kerendia to treat heart failure
Jul 14, 2025 8:39am
Manufacturing issues stunt Unicycive's kidney disease prospect
Jun 30, 2025 11:15am
Second Novartis drug in IgAN troika crosses FDA finish line
Apr 3, 2025 10:56am